STAT
AUGUST 2, 2023
Simon Matthews made three trips this spring to the emergency room of his local hospital in Eastbourne, on England’s southeast coast, before doctors managed to figure out what was making him so ill. He had a fever of 104 Fahrenheit, uncommonly high for an adult. On his first foray to the hospital — in an ambulance — it was feared he had meningitis.
PharmaVoice
AUGUST 2, 2023
The biotech’s 2019 trial halt was a major disappointment in NASH, but a turnaround has shown late-stage potential in another liver disease with unmet needs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
AUGUST 2, 2023
All great stories have complicated endings. But that doesn’t mean they can’t offer simple and instructive lessons. Christopher Nolan’s magnum opus , “Oppenheimer,” highlights the tragic story about the “father of the atomic bomb.” But it’s also a story about how the United States missed an opportunity to be a global leader in the development of an innovation that would define the 20 th century.
Pharma Times
AUGUST 2, 2023
The University of Strathclyde, the NHS and New York University join forces to increase knowledge - News - PharmaTimes
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
AUGUST 2, 2023
I should be irate and despondent about the Supreme Court’s scrapping of affirmative action in admissions. It’s several steps backward. And yet, I have mixed emotions about the practice, informed by my own experiences with affirmative action.
The Pharmacist
AUGUST 2, 2023
The government is considering further extending the pool of professionals who can sign fit notes. The Government is currently consulting on changes to its guidance, following recent legislative changes to fit notes. Last year, changes to the legislation enabled nurses, occupational therapists, pharmacists, and physiotherapists to legally certify fit notes.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Drug Patent Watch
AUGUST 2, 2023
In the world of prescription drugs, brand-name manufacturers have employed various strategies to maintain revenue streams in the face of generic competition. One such strategy is the use of “authorized… The post Understanding the Impact of Authorized Generics on Drug Pricing: The Entacapone Case Study appeared first on DrugPatentWatch - Make Better Decisions.
STAT
AUGUST 2, 2023
Roughly 7.7% of Americans didn’t have any health insurance as of this past March — a “record low” uninsured rate, according to the latest health insurance survey from the Centers for Disease Control and Prevention. However, that uninsured rate — which still translated to more than 25 million Americans with no health coverage — is almost certainly higher now.
European Pharmaceutical Review
AUGUST 2, 2023
A new COVID-19 vaccine has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA). Bimervax is now the ninth vaccine to be authorised by the UK’s independent medicines regulator to treat the virus. MHRA authorisation of Bimervax The COVID-19 vaccine, developed by HIPRA Human Health, combines a part of the SARS-CoV-2 virus spike protein with an adjuvant, according to the MHRA.
STAT
AUGUST 2, 2023
Vertex Pharmaceuticals has spent decades trying to develop molecules that reduce pain safely and potently, searching for success in a field its own executives have dubbed a graveyard for drug discovery. Detailed data published Wednesday lent support to that quest, with a pair of company-sponsored clinical trials showing an experimental non-opioid therapy reduced pain after surgery.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Express Pharma
AUGUST 2, 2023
How do you see the global digital health scenario evolving in India, given the vulnerability of our health data, yet the promise of health insights to drive better health outcomes? Digital Health is now being used at different levels in the value chain and across the continuum of care. For seeking healthcare-related information, seven out of 10 people will search the internet, similarly for medical information.
STAT
AUGUST 2, 2023
Rise and shine, everyone. The middle of the week is upon us. Have heart, though. You made it this far, so why not hang on for another couple of days, yes? And what better way to make the time fly than to keep busy. So grab that cup of stimulation — our flavor today boasts the aroma of bananas — and get started. Meanwhile, do keep us in mind if you hear anything interesting.
The Pharmacist
AUGUST 2, 2023
A group of researchers have set up a network to encourage collaboration between pharmacists and pharmacy technicians working in general practice and primary care networks (PCNs) and those who are involved in research relating to primary care pharmacy. Members will be encouraged to share knowledge and skills relating to primary care and clinical pharmacy, as […] The post GP and PCN pharmacists invited to join clinical pharmacy network appeared first on The Pharmacist.
European Pharmaceutical Review
AUGUST 2, 2023
Research published in Biotechnology and Bioengineering has demonstrated two innovative, automatic, online, real-time sample acquisition and preparation systems for in-process monitoring, control, and release of biopharmaceuticals. The proposed autonomous process analytical technology (PAT) platform comprises of a micro sequential injection (µSI) process analyser and automatic assay preparation platform (A2P2) for use in the laboratory as an off-line analytical system and on the manufacturing flo
BioPharma Dive
AUGUST 2, 2023
Intergalactic, a developer of non-viral gene therapies built by ex-Biogen executive Michael Ehlers, is folding less than two years after its launch.
Pharmaceutical Technology
AUGUST 2, 2023
Tyra Biosciences has received orphan drug designation (ODD) from the US FDA for TYRA-300 to treat achondroplasia, a common form of dwarfism.
Pharma Times
AUGUST 2, 2023
The deal covers 13 brands across six therapeutic areas, mainly focused on pain treatment - News - PharmaTimes
BioPharma Dive
AUGUST 2, 2023
Yosemite is one of a new class of biotech venture funds that also includes the recently launched Dimension and Cure Ventures.
Pharmaceutical Technology
AUGUST 2, 2023
Two lots of Lupin’s Tydemy have been recalled due to a decrease in ascorbic acid levels leading to reduced effectiveness.
Express Pharma
AUGUST 2, 2023
ESG has been topping the pharma agenda for some time, but recently, there’s been a step change, with growing momentum. Individual businesses are moving away from working in silos, adopting a collaborative approach, sharing insights and learnings to benefit from the whole pharma industry’s ESG credentials. Greater emphasis is also being placed on ESG in tender and investment decisions – a cause for optimism.
Outsourcing Pharma
AUGUST 2, 2023
Dr. Susan Wood is CEO and president of VIDA Diagnostics. She has over 25 years of experience championing clinical intelligence solutions into routine clinical use.
Pharmaceutical Technology
AUGUST 2, 2023
Pfizer has posted a reported net income of $2.36bn for Q2 2023, a drop of 77% from nearly $10bn in the same quarter of 2022.
PharmaTech
AUGUST 2, 2023
A comprehensive understanding of what makes mRNA vaccines tick is crucial in charting the future of the market.
Express Pharma
AUGUST 2, 2023
Supriya Lifescience, a Mumbai-based company specialising in active pharmaceutical ingredients (API), proudly announces its recent collaboration with Plasma Nutrition, a US-based company. The strategic partnership involves an exclusive technology licensing agreement, granting Supriya Lifescience the sole rights for manufacturing and marketing Ingredient Optimised Protein (ioProtein) in India.
Pharmaceutical Commerce
AUGUST 2, 2023
CDMO’s Taoyuan City plant is set to provide customers with products ranging from emulsions to gels.
PharmExec
AUGUST 2, 2023
Webinar Date/Time: Thursday, September 28th, 2023 at 10am EDT | 7am PDT | 3pm BST | 4pm CEST
Express Pharma
AUGUST 2, 2023
Centhaquine, a first-in-class drug developed by Pharmazz India, a majority-owned subsidiary of Pharmazz, has received approval from the US-FDA to enter phase 3 clinical trials in the US and the EU. Pharmazz, a Delaware Corporation based in Illinois, US is a biopharma company focused on discovering, acquiring, developing, and commercialising therapeutics that target critical care medicine.
pharmaphorum
AUGUST 2, 2023
Samsung seeks 'interchangeable' label for Humira biosimilar Phil.
PharmaTech
AUGUST 2, 2023
mRNA may be a modality whose chief advances are yet to come.
pharmaphorum
AUGUST 2, 2023
GSK takes RSV jab rivalry with Pfizer into the courts Phil.
World Pharma News
AUGUST 2, 2023
Despite significant advances in treatment and access to therapy, the human immunodeficiency virus remains a global health challenge with almost 40 million affected individuals, no vaccine and no cure. The virus attacks the person's immune cells (helper T cells, macrophages, and dendritic cells) damaging their ability to mount an immune response.
BioPharma Dive
AUGUST 2, 2023
The biotech, which has struggled to grow sales of its medicine Xpovio, is laying off 20% of its staff and focusing on late-stage studies in endometrial cancer and myelofibrosis.
PharmaTech
AUGUST 2, 2023
Thermo Fisher Scientific’s Gibco OncePro Tumoroid Culture Medium Kit was specifically developed for the expansion of patient-derived tumoroids from multiple cancer indications.
pharmaphorum
AUGUST 2, 2023
AI-powered computer vision accelerates innovation Mike.
Pharmacy Joe
AUGUST 2, 2023
In this episode, I’ll discuss a resource for taking care of patients with a rare disease. Episode 840: A Rare Disease Resource Every Hospital Pharmacist Should Know About Subscribe on iTunes , Android , or Stitcher There exists a large number of rare diseases that any given hospital pharmacist might encounter once in their practice, if at all. Many of these diseases are exacerbated by certain medications but because of their rarity this information is not in tertiary medication references, train
Expert insights. Personalized for you.
246 
Let's personalize your content